In July 2009, Cardium completed the sale of its InnerCool Therapies medical device company Royal Philips Electronics, the first asset monetization from the Company’s biomedical investment portfolio.. About Cardium – Cardium is on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that for significant unmet for significant unmet medical needs and definable pathways to commercialization address, partnering and other economic monetizations focus. Cardium ‘s investment portfolio includes the Tissue Repair Company and Cardium Biologics, medical technology companies the the development of innovative therapeutic healing, For example, indications concentrated.
Sustained, localized micro – release of PDGF-B by a patient’s own cells directly to the wound is believed to stimulate angiogenesis and granulation tissue formation by the recruitment and proliferation of cells such as monocytes, fibroblasts and endothelial cells. These cell types are critical for the effective stimulation of a variety of wound healing processes.. Innovative Advanced Care DNA – Based TherapyExcellarate is an advanced care DNA – based biologic product candidate that is currently designed to physicians and patients with a potentially simpler and easy to deploy, the treatment treatment, medical devices, Based on the positive data from a Phase 1/2 study, the Company believes that the Excellarate topical gel a unique opportunity provides for: improve patient compliance, based on a one-or two – treatment regimen, and acceptance by the medical community due to improved ease of use shelf life when compared to other treatment options.Hummus style pizza pie 1 can of chickpeas 3 tbsp. Nut butters such as almond butter 1 lemon 1 clove of garlic four wholemeal pocket-less Pita or lavash.